Type 2 diabetes clinical pipeline in the U.S. in 2018, by type and phase

This statistic depicts the number of new clinical trials for type 2 diabetes in the U.S. as of September 2018, by type and phase. As of that time, among phase I clinical trials for diabetes, 18 were for novel chemicals with new mechanisms of action.

Clinical pipeline for type 2 diabetes drugs in the U.S. as of 2018, by type and phase

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date



United States

Survey time period

as of September 2018

Special properties

84 programs in type 2 diabetes clinical pipeline

Supplementary notes

NDA/BLA = New drug application/biologic license application approvals
MOA = mechanism of action

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Clinical trials"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.